Lloyd Price

OCTOBER 14, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Regulatory Landscape: Changes in healthcare regulations and policies.

Leadership 55

Leadership healthcare technology Digital Health Mental health 55

Lloyd Price

DECEMBER 2, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Mental health 61

Mental health Digital Health healthcare technology Telehealth 61

Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia. After earning his M.D.

Leadership 88

Leadership Pharmaceuticals Drug Development Digital Health 88

Healthcare IT Today

JANUARY 7, 2025

As these implementations take hold, the emphasis will be on demonstrating measurable return on investment (ROI), with AI driving down administrative burdens, accelerating drug development, and significantly improving operational efficiency. What’s most exciting to me is AI’s potential impact on personalized medicine.

Health IT 93

Health IT Life Science Drug Development Pharmaceuticals 93

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Interoperability 68

Interoperability healthcare technology HIPAA Leadership 68

Lloyd Price

NOVEMBER 8, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Healthcare IT Today

MARCH 15, 2024

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

Pharmaceuticals 122

Pharmaceuticals Drug Development Mental health Nursing 122

Lloyd Price

JANUARY 20, 2025

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value > [link] Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.

Mental health 58

Mental health healthcare technology Telehealth Digital Health 58

Lloyd Price

MAY 30, 2024

Hospitals and healthcare systems are increasingly implementing AI tools for tasks like medical imaging analysis, drug discovery, and even robot-assisted surgery. With this rapid adoption, there's a need for dedicated leadership to guide responsible and strategic implementation.

Leadership 68

Leadership healthcare technology Interoperability Drug Development 68

Lloyd Price

DECEMBER 2, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Digital Health 55

Digital Health healthcare technology Telemedicine Leadership 55

Lloyd Price

AUGUST 3, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Drug development: Assessing treatment efficacy and patient adherence.

Mental health 66

Mental health Pain management Drug Development Leadership 66

Healthcare IT Today

JANUARY 22, 2025

Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drug development and discovery process. One area where the need for diversity has never been greater is clinical trials.

EHR 82

EHR Drug Development Remote care Interoperability 82

Lloyd Price

NOVEMBER 21, 2023

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Drug Development 66

Drug Development Health science healthcare technology Leadership 66

Lloyd Price

FEBRUARY 7, 2025

Management Team: The experience, track record, and leadership of the management team can be a key factor in valuation. In conclusion, the stage of a company's development is a crucial determinant of its valuation multiple.

healthcare technology 66

healthcare technology Leadership Drug Development Pharmaceuticals 66

Lloyd Price

SEPTEMBER 16, 2024

Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Conference attendees discussed the latest trends in biopharma innovation, including gene therapy, cell therapy, and antibody-drug conjugates.

Digital Health 61

Digital Health Drug Development healthcare technology Leadership 61

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare.

healthcare technology 68

healthcare technology Leadership Drug Development Digital Health 68

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Email lloyd@nelsonadvisors.co.uk Visit [link]

healthcare technology 68

healthcare technology Drug Development Leadership Digital Health 68

Lloyd Price

AUGUST 7, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Interoperability 58

Interoperability Leadership EHR Drug Development 58

Lloyd Price

FEBRUARY 18, 2024

AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 61

Pharmaceuticals healthcare technology Digital Health Remote care 61

Lloyd Price

NOVEMBER 21, 2018

In an interview with the Wall Street Journal, Narasimhan pointed to some of the investments the company has made into the cutting-edge areas of drug development, such as gene therapy and radiopharmaceuticals.

Drug Development 42

Drug Development Leadership 42

Lloyd Price

OCTOBER 9, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Here are some key areas where we anticipate significant growth: 1.

Mental health 58

Mental health healthcare technology Leadership Digital Health 58

Lloyd Price

APRIL 22, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Pharma giants acquiring AI drug discovery firms: Pharmaceutical companies are increasingly looking to AI to streamline drug development, leading to potential acquisitions. Email lloyd@nelsonadvisors.co.uk

healthcare technology 58

healthcare technology Leadership Drug Development Digital Health 58

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 58

Pharmaceuticals healthcare technology Leadership Drug Development 58

Lloyd Price

MAY 6, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. AI can optimise clinical trial design and patient selection, leading to faster and more efficient drug development processes. Email lloyd@nelsonadvisors.co.uk Email lloyd@nelsonadvisors.co.uk Visit [link]

healthcare technology 66

healthcare technology Leadership Drug Development Digital Health 66

Healthcare IT Today

FEBRUARY 28, 2020

New healthcare AI and Machine Learning research conducted by Healthcare IT Today suggests that many industry leaders are serious about adopting healthcare AI and machine learning tools and what’s more, that these technologies are being used as part of mission-critical efforts rather than one-off pilot tests.

Health IT 120

Health IT Healthcare IT Drug Development Patient Experience 120

Lloyd Price

JULY 15, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Digital Health 58

Digital Health Mobile Health Telehealth Mental health 58

Lloyd Price

FEBRUARY 2, 2024

Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data 61

Health Data Interoperability healthcare technology Leadership 61

Lloyd Price

SEPTEMBER 6, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 71

Leadership Drug Development healthcare technology Digital Health 71

Lloyd Price

SEPTEMBER 29, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 61

Leadership Drug Development healthcare technology Digital Health 61

Lloyd Price

FEBRUARY 22, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pain management 55

Pain management Mental health Telehealth healthcare technology 55

Healthcare IT Today

JANUARY 3, 2025

AI capabilities will become a critical differentiator, with companies that successfully implement AI solutions gaining significant advantages in drug discovery and development speed, cost reduction, and market intelligence. It’s not just a trend, but a reality we fully expect will accelerate in the coming year.

Health IT 92

Health IT Pharmaceuticals Drug Development Life Science 92

Digital Health Global

NOVEMBER 7, 2024

This enables us to provide full support from our portfolio of services to all drug developers, from formulation development to patient onboarding.” This collaboration further strengthens Aptar Pharma’s leadership in respiratory by offering a broader range of drug delivery formats, solutions and services.

Healthcare Innovation 88

Healthcare Innovation Pharmaceuticals Drug Development Leadership 88

Healthcare IT Today

DECEMBER 31, 2024

This collaboration will drive innovations such as faster drug development and coordinated patient care. Public cloud infrastructure will bridge gaps between healthcare providers, payers, and pharmaceutical companies, promoting seamless data sharing.

Interoperability 65

Interoperability Health IT Pharmaceuticals Digital Health 65

Digital Health Global

MARCH 16, 2023

We are excited to support Seamless Therapeutics in its pursuit of taking a leadership position in the rapidly evolving gene editing arena,” added Karl Nägler, PhD, Managing Partner at Wellington Partners. “At billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare IT Today

MAY 5, 2023

Technology continues to play a large role in healthcare, expediting and reducing the costs associated with the drug development process. The implementation of AI has been instrumental in significantly cutting down the drug development timeline and creating viable drug targets in a more timely and cost-efficient manner.

Drug Development 111

Drug Development Primary Care Remote care Patient Experience 111